| Array BioPharma Announces Abstracts Selected for Presentation at 2010 ASCO Annual Meeting (Business Wire) BOULDER, Colo.----Array BioPharma Inc. today announced that four abstracts have been selected for presentation at the American Society of Clinical Oncology Annual Meeting, being held from June 4-8, 2010, in Chicago, Illinois. us.rd.yahoo.com |
FDA Unlikely to Approve Zalbin Dose Human Genome Sciences said the FDA likely won't approve its effort to sell a hepatitis C drug in a dose that is taken every two weeks, expressing concern about the "risk benefit." online.wsj.com |
A Band Aid for Runners Pain in the front of the knee is common among runners and other athletes. A patella band, a thin pressure strip worn under the knee, can help alleviate the pain. online.wsj.com |
Pfizer Agrees to Acquire FoldRx Pfizer agreed to buy privately held FoldRx Pharmaceuticals, whose leading drug candidate is a therapy for a genetic neurodegenerative disease for which the only current therapy is a liver transplant. online.wsj.com |
Theravance Inc. CEO Discusses Q3 2010 Results - Earnings Call Transcript Theravance Inc. (THRX) Q3 2010 Earnings Call October 21, 2010 5:00 pm ETComplete Story » seekingalpha.com |